Re-using residual drug during intravenous infusion treatment
To minimize drug loss residual drug from an intravenous infusion are sometimes used on multiple patients. The non-return valves in the infusion system should in theory prevent the rest of the system from being contaminated. There are currently no Swedish guidelines for if this is appropriate or not.
Bekymringssamtal (a conversation of concern)
CBT delivered by chat to people with depression or anxiety
Dialectical behavior therapy for suicide and self-harm
Covid-19 and pregnancy
Patient Directed Financial Incentives (P4P4P) to change health related-behaviours
Virtual Reality in the treatment of eating disorders
Management of incidentally found pancreatic cysts
Long-term symptoms of the disease Covid-19
SBU and COVID-19
SBU closely monitors what actions other countries are taking to meet the needs of decision- and policymakers to respond to the COVID-19 pandemic. Via the International organisation of HTA, INAHTA, SBU shares and exchanges information to support staff and decision-makers in health care and social services.
SBU is also in contact with the other Swedish agencies within the national health care sector who currently are working intensively to support both the health care services as well as care homes.
